Inventor · disambiguated record
Sheng-Jiun Wu
Also filed as: WU SHENG-JIUN
36 granted patents·11 pending applications·522 citations·filing 2005–2024
98Inventor score
Top patents by PatentIndex Score
47 records- 0198US8226611B2Anti-IL-6 antibodies, compositions, methods and usesCHEN YAN·Filed 2011·Granted Jul 24, 2012·64 cites·8 claims
- 0298US7560112B2Anti-il-6 antibodies, compositions, methods and usesAPPLIED MOLECULAR EVOLUTION·Filed 2006·Granted Jul 14, 2009·84 cites·16 claims
- 0397US8623362B2Anti-IL-6 antibodiesCHEN YAN·Filed 2012·Granted Jan 7, 2014·44 cites·11 claims
- 0497US8067003B2Methods of treating conditions using anti-IL-6 antibodiesCHEN YAN·Filed 2010·Granted Nov 29, 2011·46 cites·12 claims
- 0597US7833755B2Anti-IL-6 antibody nucleic acid molecules and methodsCHEN YAN·Filed 2009·Granted Nov 16, 2010·50 cites·12 claims
- 0694USRE43672EAnti-IL-6 antibodies, compositions, methods and usesCHAN YAN·Filed 2011·Granted Sep 18, 2012·47 cites·16 claims
- 0792US9850310B2CD123 binding agents and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Dec 26, 2017·23 cites·20 claims
- 0892US9090694B2ST2L antibody antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Jul 28, 2015·19 cites·4 claims
- 0991US9522957B2Method of treating an inflammatory condition by administering toll-like 3 receptor antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 20, 2016·10 cites·7 claims
- 1091US9371376B2Anti-PHF-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2012·Granted Jun 21, 2016·10 cites·11 claims
- 1190US9481731B2Toll-like receptor 3 antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Nov 1, 2016·9 cites·10 claims
- 1290US9255153B2Polynucleotides encoding Toll-Like Receptor 3 antagonistsCUNNINGHAM MARK·Filed 2013·Granted Feb 9, 2016·10 cites·9 claims
- 1390US9212227B2ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditionsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 15, 2015·13 cites·15 claims
- 1490US8519107B2IL-17A antibodiesALMAGRO JUAN CARLOS·Filed 2010·Granted Aug 27, 2013·24 cites·16 claims
- 1589US8951525B2Human tissue factor antibody and uses thereofJANSSEN BIOTECH INC·Filed 2013·Granted Feb 10, 2015·11 cites·17 claims
- 1689US8722044B2Human tissue factor antibody and uses thereofALMAGRO JUAN CARLOS·Filed 2012·Granted May 13, 2014·12 cites·19 claims
- 1788US10894830B2Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their usesJANSSEN BIOTECH INC·Filed 2016·Granted Jan 19, 2021·7 cites·21 claims
- 1888US10196440B2Anti-PHG-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2018·Granted Feb 5, 2019·3 cites·8 claims
- 1988US8999333B2Human tissue factor antibody and uses thereofJANSSEN BIOTECH INC·Filed 2014·Granted Apr 7, 2015·9 cites·15 claims
- 2087US10781246B2Compositions and methods for anti-staphylococcal biologic agentsUNIV NEW YORK·Filed 2016·Granted Sep 22, 2020·5 cites·15 claims
- 2186US10844122B2Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereofJANSSEN BIOTECH INC·Filed 2016·Granted Nov 24, 2020·4 cites·8 claims
- 2284US10000559B2Anti-PHF-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2017·Granted Jun 19, 2018·2 cites·18 claims
- 2384US9951137B2ST2L antagonists and methods of useJANSSEN BIOTECH INC·Filed 2015·Granted Apr 24, 2018·4 cites·6 claims
- 2482US9238693B2Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodiesCUNNINGHAM MARK·Filed 2013·Granted Jan 19, 2016·3 cites·9 claims
- 2581US12065488B2Anti-IL-6 antibodyJANSSEN BIOTECH INC·Filed 2021·Granted Aug 20, 2024·0 cites·4 claims
- 2680US8409567B2Toll-like receptor 3 antagonistsCUNNINGHAM MARK·Filed 2009·Granted Apr 2, 2013·2 cites·17 claims
- 2778US9932404B2Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonistJANSSEN BIOTECH INC·Filed 2016·Granted Apr 3, 2018·1 cites·18 claims
- 2878US8540986B2Toll-like receptor 3 antagonistsCUNNINGHAM MARK·Filed 2010·Granted Sep 24, 2013·2 cites·9 claims
- 2977US2025215079A1Antibodies specifically binding pd-1, tim-3 or pd-1 and tim-3 and their usesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 3076US10450377B2ST2L antagonists and methods of useJANSSEN BIOTECH INC·Filed 2018·Granted Oct 22, 2019·1 cites·18 claims
- 3175US9745371B2Anti-PHF-tau antibodies and their usesJANSSEN BIOTECH INC·Filed 2016·Granted Aug 29, 2017·1 cites·15 claims
- 3274US11180549B2Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibodyJANSSEN BIOTECH INC·Filed 2019·Granted Nov 23, 2021·0 cites·12 claims
- 3373US8460659B2Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseasesCUNNINGHAM MARK·Filed 2011·Granted Jun 11, 2013·2 cites·5 claims
- 3467US12173064B2Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their usesJANSSEN BIOTECH INC·Filed 2020·Granted Dec 24, 2024·0 cites·30 claims
- 3567US9340613B2Anti-IL-6 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2013·Granted May 17, 2016·0 cites·9 claims
- 3667US2025188163A1Gprc5d antibodies with enhanced effector function and uses thereofJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 3766US2018179294A1Toll-like receptor 3 antagonistsJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 3865US2017253651A1Methods of Suppressing Rheumatoid Arthritis Using An Anti-IL-6 AntibodyJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 3964US9631016B2Pen-injector device containing anti-IL-6 antibodiesJANSSEN BIOTECH INC·Filed 2016·Granted Apr 25, 2017·0 cites·13 claims
- 4050US11866499B2Monospecific and multispecific anti-TMEFF2 antibodies and their usesJANSSEN BIOTECH INC·Filed 2019·Granted Jan 9, 2024·0 cites·23 claims
- 4149US2014017250A1Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesCUNNINGHAM MARK·Filed 2013·Application pending·0 cites
- 4244US2006159695A1Anti-respiratory syncytial virus antibodies, antigens and uses thereofDELVECCHIO ALFRED·Filed 2005·Application pending·0 cites
- 4341US2013090457A1Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesCUNNINGHAM MARK·Filed 2012·Application pending·0 cites
- 4441US2010254992A1Anti-mcp-1 antibodies, compositions, methods and usesDAS ANUK·Filed 2008·Application pending·0 cites
- 4538US2011027294A1Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses ThereofDELVECCHIO ALFRED·Filed 2010·Application pending·0 cites
- 4637US2017210799A1Anti-ror1, antibodies, ror1 x cd3 bispecific antibodies, and methods of using the sameJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 4734US2018355043A1Antibodies Specifically Binding HLA-DR and Their UsesJANSSEN BIOTECH INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sheng-Jiun Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →